Form 4: Veracyte Director Sells Shares
Insider Transaction (Form 4)
Jens Holstein, a Director of Veracyte, Inc., sold 15,000 shares of common stock on September 24, 2026.
Summary
- Option exercise/conversion: acquired 7,500 Common Stock at $35.30 ($264,750) on September 24, 2026; holds 34,971 after (Direct).
- Open-market sale: disposed of 7,500 Common Stock at $47.00 ($352,500) on September 24, 2026; holds 27,471 after (Direct).
- Option exercise/conversion: acquired 7,500 Common Stock at $35.30 ($264,750) on October 27, 2026; holds 34,971 after (Direct).
- Open-market sale: disposed of 7,500 Common Stock at $50.00 ($375,000) on October 27, 2026; holds 27,471 after (Direct).
- Option exercise/conversion: disposed of 7,500 Stock Option (right to buy) on September 24, 2026; holds 27,500 after (Direct).
- Option exercise/conversion: disposed of 7,500 Stock Option (right to buy) on October 27, 2026; holds 20,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $727,500 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jens Holstein — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-24 | Option exercise/conversion | Common Stock | 7,500 | $35 | $264.8K | 34,971 |
| 2026-09-24 | Open-market sale | Common Stock | 7,500 | $47 | $352.5K | 27,471 |
| 2026-10-27 | Option exercise/conversion | Common Stock | 7,500 | $35 | $264.8K | 34,971 |
| 2026-10-27 | Open-market sale | Common Stock | 7,500 | $50 | $375.0K | 27,471 |
| 2026-09-24 | Option exercise/conversion | Stock Option (right to buy) | 7,500 | — | — | 27,500 |
| 2026-10-27 | Option exercise/conversion | Stock Option (right to buy) | 7,500 | — | — | 20,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-24 | Option exercise/conversion (7,500 shares) |
| 2026-09-24 | Open-market sale (7,500 shares) |
| 2026-10-27 | Option exercise/conversion (7,500 shares) |
| 2026-10-27 | Open-market sale (7,500 shares) |
| 2026-09-24 | Option exercise/conversion (7,500 shares) |
| 2026-10-27 | Option exercise/conversion (7,500 shares) |
Keywords
insider transaction, Form 4, VCYT, VERACYTE, INC., bearish, Jens Holstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.